# Sanofi's Modulus Project Named 2026 ISPE Facility of the Year Overall Winner

> Sanofi's Modulus project took the 2026 ISPE Facility of the Year Overall Winner award for twin modular vaccine plants in France and Singapore.

- Published: 2026-10-19T14:25:53+00:00
- Section: Business
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-19/sanofi-modulus-ispe-facility-of-the-year
- Source: [PR Newswire](https://www.prnewswire.com/news-releases/ispe-names-sanofi-sa-the-2026-ispe-facility-of-the-year-awards-foya-overall-winner-for-its-modulus-project-302912661.html)

## Key takeaways

- ISPE named Sanofi's Modulus project the 2026 Facility of the Year Awards Overall Winner at its annual meeting in Washington, D.C.
- Modulus covers twin manufacturing facilities in Neuville-sur-Saône, France, and Tuas, Singapore, built on a modular plug-and-produce design.
- The 2027 FOYA submission period closes on December 7, with finalists to be named at a conference in Long Beach, California, on February 1-2, 2027.

[Sanofi](https://akta.pro/company-profiles/00000ls/sanofi) has been named the 2026 ISPE Facility of the Year Awards Overall Winner for its Modulus project, the International Society for Pharmaceutical Engineering announced on October 19, 2026. The award, the program's highest recognition, was presented at the ISPE FOYA Banquet and Awards Celebration during the 2026 ISPE Annual Meeting & Expo in Washington, D.C., [PR Newswire](https://www.prnewswire.com/news-releases/ispe-names-sanofi-sa-the-2026-ispe-facility-of-the-year-awards-foya-overall-winner-for-its-modulus-project-302912661.html) reported.

## Sanofi's Modulus Project and Its Twin Sites

Sanofi is a global biopharmaceutical company that develops and commercializes prescription medicines, vaccines, and consumer healthcare products across immunology, neurology, oncology, rare diseases, and vaccines, serving patients and healthcare systems in more than 100 countries. Its [Modulus project](https://www.sanofi.com) features twin manufacturing facilities in Neuville-sur-Saône, France, and Tuas, Singapore, designed to support flexible vaccine and biologics production.

The facilities are built around a modular "plug-and-produce" architecture, with adaptable production spaces, advanced automation, autonomous mobile robots, and digital twin technology. That design enables rapid reconfiguration across multiple products and manufacturing platforms, and the standardized facility design is intended to accommodate multiple products and processes over the life of the sites.

"Sanofi's Modulus project stands out for its innovative approach to facility design, combining modular architecture, digital integration, and operational flexibility to support the evolving needs of vaccine and biologics production," said Parag Sane, Chair of the Facility of the Year Awards Judging Committee.

Before the overall honor, Modulus was announced as a 2026 ISPE FOYA Submission Finalist at the 2026 ISPE Facilities of the Future Conference and as the 2026 ISPE FOYA Category Winner for Facility of the Future at the 2026 ISPE Europe Annual Conference earlier this year.

## Sanofi's Scale and Recent Moves

Sanofi's footprint extends to 70 countries with more than 83,000 employees, according to akta.pro [company records](https://akta.pro/company-data). The same records list six funding rounds, including a $2.7 billion post-IPO debt round in April 2026, a $3 billion post-IPO debt round in October 2025, a $1.7 billion post-IPO debt round in June 2025, and a $1.6 billion post-IPO debt round in March 2025.

## Earlier Sanofi Developments

On October 17, 2026, FAZ.NET reported that Sanofi plans the first shovel strike for a new insulin factory on Monday, a billion-euro investment in Frankfurt. On October 16, 2026, WebWire reported that Sanofi will become the first company to sponsor the white jersey for both the Tour de France and the Tour de France Femmes avec Zwift. On October 15, 2026, Newswire reported that Sanofi and the pan-Canadian Pharmaceutical Alliance signed a Letter of Intent for Dupixent across four new indications in dermatology and respiratory care.

## What Comes Next for the FOYA Program

The call for submissions for the 2027 FOYA program is open and ends Monday, December 7. The 2027 ISPE FOYA Submission Finalists will be announced at the 2027 ISPE Facilities of the Future Conference, taking place February 1-2, 2027, in Long Beach, California.

## Companies in this story

- [Sanofi company profile](https://akta.pro/company-profiles/00000ls/sanofi) · website: https://www.sanofi.com

---
News for Agent · https://newsforagent.com/llms.txt